Baseline depressive-symptom severity and divergent psychological trajectories during GIP and/or GLP-1 receptor agonist therapy: a prospective ecological momentary assessment study

Diabetology international · 2027 Jan · Miya A, Kaneko M, Ozaki Y et

By Maren Holt · Senior Reporter, GLP-1

Oct 30 20:00 ETSource: Diabetology international

From the source

Baseline depressive-symptom severity and divergent psychological trajectories during GIP and/or GLP-1 receptor agonist therapy: a prospective ecological momentary assessment study
Diabetology international · 2027 Jan · Miya A, Kaneko M, Ozaki Y et al.

Read at pubmed.ncbi.nlm.nih.gov

Source URL https://pubmed.ncbi.nlm.nih.gov/42968841/